Trevi Therapeutics, Inc.
TRVI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,802 | -$12,301 | -$10,340 | -$11,415 |
| Dep. & Amort. | $38 | $38 | $37 | $38 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,243 | $1,384 | $1,208 | $917 |
| Change in WC | -$169 | $1,051 | -$4,099 | $1,009 |
| Other Non-Cash | -$190 | -$273 | -$283 | -$99 |
| Operating Cash Flow | -$10,880 | -$10,101 | -$13,477 | -$9,550 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$12 | $0 | $0 | -$7 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$71,610 | -$17,110 | -$27,546 | -$45,192 |
| Inv. Sales/Matur. | $20,684 | $14,117 | $17,595 | $21,327 |
| Other Inv. Act. | $0 | $383 | $0 | $0 |
| Investing Cash Flow | -$50,938 | -$2,610 | -$9,951 | -$23,872 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$11 | -$31 |
| Stock Issued | $0 | $110,395 | $0 | $51,449 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,629 | $0 | $8,716 | $49 |
| Financing Cash Flow | $1,629 | $110,395 | $8,705 | $51,467 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$60,189 | $97,684 | -$14,723 | $18,045 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $117,058 | $19,374 | $34,097 | $16,052 |
| End Cash | $56,869 | $117,058 | $19,374 | $34,097 |
| Free Cash Flow | -$10,892 | -$10,101 | -$13,477 | -$9,557 |